Preemptive plerixafor based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation

被引：1
作者：
Vadlamani, Surya Prakash [1 ]
Kumar, Lalit [1 ]
Pramanik, Raja [1 ]
Varshney, Ankur Nandan [1 ]
机构：
[1] All India Inst Med Sci, Delhi, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
mobilisation; Multiple myeloma; plerixafor;
D O I：
10.1016/j.clml.2019.09.497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-171
引用
收藏
页码：E303 / E303
页数：1
相关论文
共 50 条
  • [1] The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma
    Uysal, Ayse
    Erkurt, Mehmet Ali
    Kuru, Irfan
    Kaya, Emin
    Berber, Ilhami
    Sarici, Ahmet
    Bicim, Soykan
    Kaya, Ahmet
    Hidayet, Emine
    MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 65 - 71
  • [2] Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario
    Kouroukis, C. T.
    Varela, N. P.
    Bredeson, C.
    Kuruvilla, J.
    Xenocostas, A.
    CURRENT ONCOLOGY, 2016, 23 (04) : E409 - E430
  • [3] Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma
    Ri, Masaki
    Matsue, Kosei
    Sunami, Kazutaka
    Shimazaki, Chihiro
    Hayashi, Akio
    Sunaga, Yoshinori
    Sasaki, Toru
    Suzuki, Kenshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 562 - 572
  • [4] Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma
    Kim, Sara S.
    Renteria, Anne S.
    Steinberg, Amir
    Banoff, Karen
    Isola, Luis
    CYTOTHERAPY, 2014, 16 (11) : 1584 - 1589
  • [5] Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma
    Masaki Ri
    Kosei Matsue
    Kazutaka Sunami
    Chihiro Shimazaki
    Akio Hayashi
    Yoshinori Sunaga
    Toru Sasaki
    Kenshi Suzuki
    International Journal of Hematology, 2017, 106 : 562 - 572
  • [6] Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma: Plerixafor Mobilization and Progression-Free Survival
    Dutari, Pilar
    Musso, Veronica
    Colombo, Evelyn
    Sol Jarchum, Maria
    Alvarez Bollea, Maria
    Mas, Emilia
    Laura Rizzi, Maria
    Lavarda, Marcelo
    Minoldo, Daniel
    Jarchum, Gustavo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S289 - S289
  • [7] Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
    Moreb, Jan S.
    ONCOLOGY REVIEWS, 2011, 5 (01) : 67 - 73
  • [8] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    I N M Micallef
    A D Ho
    L M Klein
    S Marulkar
    P J Gandhi
    P A McSweeney
    Bone Marrow Transplantation, 2011, 46 : 350 - 355
  • [9] Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
    Basak, Grzegorz W.
    Jaksic, Ozren
    Koristek, Zdenek
    Mikala, Gabor
    Basic-Kinda, Sandra
    Mayer, Jiri
    Masszi, Tamas
    Giebel, Sebastian
    Labar, Boris
    Wiktor-Jedrzejczak, Wieslaw
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (06) : 488 - 495
  • [10] Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide
    Micallef, I. N. M.
    Ho, A. D.
    Klein, L. M.
    Marulkar, S.
    Gandhi, P. J.
    McSweeney, P. A.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 350 - 355
12345